These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 31914898)

  • 1. Engineered Protein Scaffolds as Next-Generation Therapeutics.
    Gebauer M; Skerra A
    Annu Rev Pharmacol Toxicol; 2020 Jan; 60():391-415. PubMed ID: 31914898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering of binding functions into proteins.
    Gebauer M; Skerra A
    Curr Opin Biotechnol; 2019 Dec; 60():230-241. PubMed ID: 31207556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineered protein scaffolds as next-generation antibody therapeutics.
    Gebauer M; Skerra A
    Curr Opin Chem Biol; 2009 Jun; 13(3):245-55. PubMed ID: 19501012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in the development of novel protein scaffolds based therapeutics.
    Azhar A; Ahmad E; Zia Q; Rauf MA; Owais M; Ashraf GM
    Int J Biol Macromol; 2017 Sep; 102():630-641. PubMed ID: 28412342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DARPins: a new generation of protein therapeutics.
    Stumpp MT; Binz HK; Amstutz P
    Drug Discov Today; 2008 Aug; 13(15-16):695-701. PubMed ID: 18621567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in the Application of Designed Ankyrin Repeat Proteins (DARPins) as Research Tools and Protein Therapeutics.
    Boersma YL
    Methods Mol Biol; 2018; 1798():307-327. PubMed ID: 29868969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative non-antibody scaffolds for molecular recognition.
    Skerra A
    Curr Opin Biotechnol; 2007 Aug; 18(4):295-304. PubMed ID: 17643280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DARPin-Based Crystallization Chaperones Exploit Molecular Geometry as a Screening Dimension in Protein Crystallography.
    Batyuk A; Wu Y; Honegger A; Heberling MM; Plückthun A
    J Mol Biol; 2016 Apr; 428(8):1574-88. PubMed ID: 26975886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Designed ankyrin repeat proteins (DARPins): binding proteins for research, diagnostics, and therapy.
    Plückthun A
    Annu Rev Pharmacol Toxicol; 2015; 55():489-511. PubMed ID: 25562645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Designed ankyrin repeat proteins (DARPins) from research to therapy.
    Tamaskovic R; Simon M; Stefan N; Schwill M; Plückthun A
    Methods Enzymol; 2012; 503():101-34. PubMed ID: 22230567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational Modeling of Designed Ankyrin Repeat Protein Complexes with Their Targets.
    Radom F; Paci E; Plückthun A
    J Mol Biol; 2019 Jul; 431(15):2852-2868. PubMed ID: 31082438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of Fluorogen-Activating Designed Ankyrin Repeat Proteins (FADAs) as Versatile Sensor Tools.
    Schütz M; Batyuk A; Klenk C; Kummer L; de Picciotto S; Gülbakan B; Wu Y; Newby GA; Zosel F; Schöppe J; Sedlák E; Mittl PRE; Zenobi R; Wittrup KD; Plückthun A
    J Mol Biol; 2016 Mar; 428(6):1272-1289. PubMed ID: 26812208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient tumor targeting with high-affinity designed ankyrin repeat proteins: effects of affinity and molecular size.
    Zahnd C; Kawe M; Stumpp MT; de Pasquale C; Tamaskovic R; Nagy-Davidescu G; Dreier B; Schibli R; Binz HK; Waibel R; Plückthun A
    Cancer Res; 2010 Feb; 70(4):1595-605. PubMed ID: 20124480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein binders and their applications in developmental biology.
    Harmansa S; Affolter M
    Development; 2018 Jan; 145(2):. PubMed ID: 29374062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo binding and retention of CD4-specific DARPin 57.2 in macaques.
    Pugach P; Krarup A; Gettie A; Kuroda M; Blanchard J; Piatak M; Lifson JD; Trkola A; Robbiani M
    PLoS One; 2010 Aug; 5(8):e12455. PubMed ID: 20805996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DARPins Bioengineering and its Theranostic Approaches: Emerging Trends in Protein Engineering.
    Rasool M; Malik A; Hussain M; Haq KA; Butt K; Ashraf MAB; Naseer MI; Asif M; Shaikh R; Mustafa MZ; Alam Q; Rasool G; Ahmad W; Haque A; Kamal MA
    Curr Pharm Des; 2017; 23(11):1610-1615. PubMed ID: 27928961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Designed ankyrin repeat proteins (DARPins) as novel isoform-specific intracellular inhibitors of c-Jun N-terminal kinases.
    Parizek P; Kummer L; Rube P; Prinz A; Herberg FW; Plückthun A
    ACS Chem Biol; 2012 Aug; 7(8):1356-66. PubMed ID: 22568706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineered protein scaffolds as leads for synthetic inhibitors of protein-protein interactions.
    Wuo MG; Arora PS
    Curr Opin Chem Biol; 2018 Jun; 44():16-22. PubMed ID: 29803113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of novel candidate therapeutics and diagnostics based on engineered human antibody domains.
    Chen W; Gong R; Ying T; Prabakaran P; Zhu Z; Feng Y; Dimitrov DS
    Curr Drug Discov Technol; 2014 Mar; 11(1):28-40. PubMed ID: 23863097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticalin® proteins: from bench to bedside.
    Deuschle FC; Ilyukhina E; Skerra A
    Expert Opin Biol Ther; 2021 Apr; 21(4):509-518. PubMed ID: 33074019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.